| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Ann Thorac Surg 1992;54:259-263
© 1992 The Society of Thoracic Surgeons
Hôpital Cardiovasculaire et Pneumologique Louis Pradel, Lyon, France
Accepted for publication December 30, 1991.
* Address reprint requests to Dr Girard, Département d'Anesthésie-Réanimation, Hôpital Cardiovasculaire et Pneumologique Louis Pradel, BP Lyon Montchat, 69394 Lyon Cedex 03, France.
A double-blind study versus placebo was carried out to evaluate the effects of a 500-mL infusion of 30% glucose containing 300 units of ordinary insulin and 5 g of potassium chloride administered at a rate of 1.66 mL · kg–1 · h–1 for 1 hour before cardiopulmonary bypass. The hemodynamic parameters measured before and after administration of the solution, after cardiopulmonary bypass, after administration of protamine, and 3 hours after leaving the operating room showed the beneficial effect of the glucose-insulin-potassium infusion on cardiac index (+23.6% after protamine infusion) and left (+16.3% 3 hours postoperatively) and right (+47.3% after cardiopulmonary bypass) ventricular workload index with a decrease in systemic vascular resistance. For patients with a cardiac index of less than 2.5 L · min–1 · m–2 before administration of the glucoseinsulin-potassium solution, the beneficial effect on the cardiac index was further increased 3 hours postoperatively (+33%). During the postoperative period, the requirements in inotropic drugs and disturbances of rhythm were not significantly different between the two groups, although they were twofold lower in patients receiving glucose-insulin-potassium. Laboratory tests showed that postoperative hypoglycemia was more common in the glucose-insulin-potassium group but had no detrimental effects; it no longer occurs since we began administering the glucose infusion at 15 g/h over 8 hours. The data reflect the beneficial effect associated with the action of glucose-insulin-potassium on myocardial protection during heart operations and were confirmed by the hemodynamic results. This argues in favor of the routine use of this technique, especially in patients with poor ventricular function.
This article has been cited by other articles:
|
|
 |
|
  Y. Fan, A.-M. Zhang, Y.-B. Xiao, Y.-G. Weng, and R. Hetzer Glucose-insulin-potassium therapy in adult patients undergoing cardiac surgery: a meta-analysis Eur J Cardiothorac Surg, July 1, 2011; 40(1): 192 - 199. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. B. Albacker, G. Carvalho, T. Schricker, and K. Lachapelle Myocardial Protection During Elective Coronary Artery Bypass Grafting Using High-Dose Insulin Therapy Ann. Thorac. Surg., December 1, 2007; 84(6): 1920 - 1927. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. P. Patel, M. E. Pugh, S. Goldberg, and G. Eiger Hyperinsulinemic Euglycemia Therapy for Verapamil Poisoning: A Review Am. J. Crit. Care., September 1, 2007; 16(5): 498 - 503. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. D. Schipke, R. Friebe, and E. Gams Forty years of glucose-insulin-potassium (GIK) in cardiac surgery: a review of randomized, controlled trials Eur J Cardiothorac Surg, April 1, 2006; 29(4): 479 - 485. [Full Text] [PDF]
|
|
|
|
|
|
W. Bothe, M. Olschewski, F. Beyersdorf, and T. Doenst Glucose-Insulin-Potassium in Cardiac Surgery: A Meta-Analysis Ann. Thorac. Surg., November 1, 2004; 78(5): 1650 - 1657. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Doenst, W. Bothe, and F. Beyersdorf Therapy with insulin in cardiac surgery: controversies and possible solutions Ann. Thorac. Surg., February 1, 2003; 75(2): S721 - S728. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Cottin, I. Lhuillier, L. Gilson, M. Zeller, C. Bonnet, C. Toulouse, P. Louis, L. Rochette, C. Girard, and J.-E. Wolf Glucose insulin potassium infusion improves systolic function in patients with chronic ischemic cardiomyopathy Eur J Heart Fail, March 1, 2002; 4(2): 181 - 184. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Danchin Recent advances in cardioprotection during myocardial revascularization procedures: benefit of a metabolic intervention Eur. Heart J. Suppl., November 1, 2001; 3(suppl_O): O21 - O25. [Abstract] [PDF]
|
|
|
|
 |
|
 C J BROOMHEAD and M P COLVIN Glucose, insulin, and the cardiovascular system Heart, May 1, 2001; 85(5): 495 - 496. [Full Text]
|
|
|
|
 |
|
 G. E. Cimochowski, M. D. Harostock, and P. J. Foldes MINIMAL OPERATIVE MORTALITY IN PATIENTS UNDERGOING CORONARY ARTERY BYPASS WITH SIGNIFICANT LEFT VENTRICULAR DYSFUNCTION BY MAXIMIZATION OF METABOLIC AND MECHANICAL SUPPORT J. Thorac. Cardiovasc. Surg., April 1, 1997; 113(4): 655 - 666. [Abstract] [Full Text]
|
|
|
|
|
|
H. L. Lazar, G. Philippides, C. Fitzgerald, D. Lancaster, R. J. Shemin, and C. Apstein GLUCOSE-INSULIN-POTASSIUM SOLUTIONS ENHANCE RECOVERY AFTER URGENT CORONARY ARTERY BYPASS GRAFTING J. Thorac. Cardiovasc. Surg., February 1, 1997; 113(2): 354 - 362. [Abstract] [Full Text]
|
|
|
|
|
|
H. L. Lazar, X. Zhang, S. Rivers, S. Bernard, and R. J. Shemin Limiting ischemic myocardial damage using glucose-insulin-potassium solutions Ann. Thorac. Surg., August 1, 1995; 60(2): 411 - 416. [Abstract] [PDF]
|
|
|
|
|
|
L. A. Robinson, G. D. Schwarz, D. B. Goddard, W. H. Fleming, and T. A. Galbraith Myocardial protection for acquired heart disease surgery: Results of a national survey Ann. Thorac. Surg., February 1, 1995; 59(2): 361 - 372. [Abstract] [PDF]
|
|
|
|
|
|
R. Svedjeholm, E. Hkanson, and I. Vanhanen Rationale for metabolic support with amino acids and glucose-insulin-potassium (GIK) in cardiac surgery Ann. Thorac. Surg., February 1, 1995; 59(suppl_1): S15 - S22. [Abstract] [PDF]
|
|
|
|
|
|
V. T. Sanchala and M. A. Inchiosa Jr Preoperative glucose-insulin-K+ therapy for cardiac protection: What can be recommended? Ann. Thorac. Surg., August 1, 1993; 56(2): 395 - 395. [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
